Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type

Open access
Belvisi, Maria G, Saunders, Michael A, Haddad, El‐Bdaoui, Hirst, Stuart J, Yacoub, Magdi H, Barnes, Peter J, Mitchell, Jane A · 1997 · British Journal of Pharmacology

Abstract

Cyclo‐oxygenase (COX) is the enzyme that converts arachidonic acid to prostaglandin H 2 (PGH 2) which can then be further metabolized to prostanoids which modulate various airway functions. COX exists in at least two isoforms. COX‐1 is expressed constitutively, whereas COX‐2 is expressed in response to pro‐inflammatory stimuli. Prostanoids are produced under physiological and pathophysiological conditions by many cell types in the lung. However, the regulation of the different COX isoforms in human airway smooth muscle (HASM) cells has not yet been determined. COX‐1 and COX‐2 protein were measured by Western blot analysis with specific antibodies for COX‐1 and COX‐2. COX‐2 mRNA levels were assessed by Northern blot analysis by use of a COX‐2 cDNA probe. COX activity was determined by measuring conversion of either endogenous or exogenous arachidonic acid to three metabolites, PGE 2, thromboxane B 2 or 6‐ketoPGF 1α by radioimmunoassay. Under control culture conditions HASM cells expressed COX‐1, but not COX‐2, protein. However, a mixture of cytokines (interleukin‐1β (IL‐1β), tumour necrosis factor α (TNFα) and interferon γ (IFNγ) each at 10 ng ml−1) induced COX‐2 mRNA expression, which was maximal at 12 h and inhibited by dexamethasone (1 μ m; added 30 min before the cytokines). Furthermore, COX‐2 protein was detected 24 h after the cytokine treatment and the expression of this protein was also inhibited by dexamethasone (1 μ m) and cyclohexamide (10 μg ml−1; added 30 min before the cytokines). Untreated HASM cells released low or undetectable amounts of all COX metabolites measured over a 24 h period. Incubation of the cells with the cytokine mixture (IL‐1β, TNFα, IFNγ each at 10 ng ml−1 for 24 h) caused the accumulation of PGE 2 and 6‐keto‐PGF 1α. In experiments where COX‐2 metabolized endogenous stores of arachidonic acid, treatment of HASM cells with IL‐1β in combination with TNFα caused a similar release of PGE 2 to that when the three cytokines were given in combination. In other experiments designed to measure COX‐2 activity directly, cells were treated with cytokines for 24 h before fresh culture medium was added containing exogenous arachidonic acid (30 μ m for 15 min) after which PGE 2 was measured. IL‐1β and TNFα increased COX‐2 activity and an additional small increase was produced by the three cytokines in combination. These findings suggest that the increased expression of COX‐2 is intimately involved in the exaggerated release of prostanoids from HASM cells exposed to pro‐inflammatory cytokines. These data indicate a role for airway smooth muscle cells, in addition to their contractile function, as inflammatory cells involved in the production of mediators which may contribute to the inflammatory response seen in diseases such as asthma. British Journal of Pharmacology (1997) 120, 910–916; doi:10.1038/sj.bjp.0700963

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0700963

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 176

Metadata

Authors
Belvisi, M. G., Saunders, M. A., Haddad, E., Hirst, S. J., Yacoub, M. H., Barnes, P. J., & Mitchell, J. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1997-02
Volume
120
Issue
5
Pages
910-916
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1974585250
Cited by
176
References
1
FWCI
13.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.